You are viewing a free limited preview of BioMarker Strategies
For Full Access: Unlock This Company Report For $99 or Upgrade To PrivCo Premium Subscription For Full Site-Wide Access

BioMarker Strategies

Private Company Ticker Symbol™: (IOARKTP)

Business Summary

BioMarker Strategies is a privately-held cancer diagnostics company developing the novel SnapPath. BioMarker Strategies is headquartered in Baltimore, Maryland.

Overview & Corporate Organization

Basic Information

Company Tags:VC Backed
Fiscal Year End:12/31
City:Baltimore
State/Province:Maryland
Country:United States
Phone:View
Website:www.biomarkerstrategies.com

Industry Information

Industry Codes

PICS™:700505
NAICS:View
SIC:View

PrivCo Industries (Sector > Industry > Sub-Industry)

Healthcare > Medical Devices & Equipment > Medical Diagnostic Equipment

The PrivCo Industry Classification System™ (PICS) is our proprietary, modernized industry classification system, geared especially toward privately-held companies and including newer emerging sub-industries that are not reflected in other outdated industry classification systems, such as SIC and NAICS.

VC/Funding Activity

PrivCo's VC/Funding Activity table for BioMarker Strategies displays the venture capital rounds, angel investments, debt or other funding raised by BioMarker Strategies.
All data before 2006 is completely free to view! To access data from 2006 onward:
Get Full Access To This Report Now! $99 Single Company Access
 
or Upgrade to PrivCo Premium Subscription Instant Full Site-Wide Access
Currently 50% Off Until May. 31!
DateInvestorRoundInvestor Type
Aug. 2010ViewA
DetailsTotal Round A View
Sep. 2011ViewOtherVenture Capital
DetailsTotal Round Other1 View
Total of Funding Shown Above View
Notes
1According to an SEC filing,...Read More →
Full-length notes are available with Single Report Access or PrivCo Premium Subscription.

Missing a deal? Tell us about it! tips@privco.com

Supplemental Resources

For additional information on BioMarker Strategies, you can see the following:

You are viewing a free limited preview of BioMarker Strategies
For Full Access: Unlock This Company Report For $99 or Upgrade To PrivCo Premium Subscription For Full Site-Wide Access